Improving the efficiency of behavioural change interventions for the prevention of lifestyle-induced cardio-metabolic disease.

Not Applicable

Completed

• Conditions: E66; R03; E78; R73; R79; Obesity; Abnormal blood-pressure reading, without diagnosis; Disorders of lipoprotein metabolism and other lipidaemias; Elevated blood glucose level; Other abnormal findings of blood chemistry

• Registration Number: DRKS00004306
• Lead Sponsor: Bielefeld University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2010-06-16
• Study Start: 2012-08-13
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 117

Inclusion Criteria

Sedentary, with < 1 hr of exercise / week

Exclusion Criteria

currently exercising at a level that equals or exceeds the intervention's intended volume and intensity,
history of myocardial infarction, stroke, TIA or major surgery within the past 3 months,
orthopedic limitations which prevent from participation in an exercise program,
asthma or other lung disease which limits the ability to exercise at high intensity, pregnancy, drug or alcohol abuse uncontrolled or poorly controlled hypertension (SBP=160 mmHg and/or DBP=100 mmHg),
uncontrolled or poorly controlled diabetes mellitus, impairments or conditions which are preventive of participation in an exercise program.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Adherence expressed as duration (duration of participant's use of the Telehealth tool), volume (volume of weekly exercise) and latency (time between final examination and date of participant's last login).

Secondary Outcome Measures

Name	Time	Method
all end points assessed 6 months after beginning of the intervention: maximal oxygen uptake (VO2peak) measured via gas exchange analysis during ergometer based exercise testing. For the assessment of the PROCAM risk score: Total cholesterol, HDL, LDL, triglycerides, fasting glucose and hsCRP via standardized laboratory assays on venous blood samples taken in the morning following a 12-hour fast. Blood pressure measured via oscillometric method. Body composition (body fat mass, lean mass, body water) measured via multi-frequency phase-sensitive bioimpedance analysis.